Disseminated infection due to Mycobacterium malmoense in a patient infected with human immunodeficiency virus. 1994

A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego

UI MeSH Term Description Entries
D008297 Male Males
D009164 Mycobacterium Infections Infections with bacteria of the genus MYCOBACTERIUM. Infections, Mycobacterium,Infection, Mycobacterium,Mycobacterium Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
September 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
May 2001, Journal of clinical microbiology,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
June 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
July 2009, Clinical and experimental dermatology,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
December 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
August 1993, Journal of internal medicine,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
November 2008, Revue des maladies respiratoires,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
May 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
January 1991, Annales de dermatologie et de venereologie,
A Chocarra, and A Gonzalez Lopez, and M F Breznes, and A Canut, and J Rodriguez, and J M Diego
December 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!